{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:02:57Z","timestamp":1793300577811,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["PO1AG09466"],"award-info":[{"award-number":["PO1AG09466"]}]},{"name":"NIH","award":["P30AG10161"],"award-info":[{"award-number":["P30AG10161"]}]},{"name":"NIH","award":["AG043375"],"award-info":[{"award-number":["AG043375"]}]},{"name":"NIH","award":["AG42146"],"award-info":[{"award-number":["AG42146"]}]},{"name":"NIH","award":["AG014449"],"award-info":[{"award-number":["AG014449"]}]},{"name":"NIH","award":["AG17617"],"award-info":[{"award-number":["AG17617"]}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","award":["IIRG-12-237253"],"award-info":[{"award-number":["IIRG-12-237253"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.neuropharm.2013.10.018","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T19:01:37Z","timestamp":1382727697000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment"],"prefix":"10.1016","volume":"79","author":[{"given":"Scott E.","family":"Counts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Alldred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoli","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott J.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.10.018_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jneumeth.2008.10.027","article-title":"Terminal continuation (TC) RNA amplification without second strand synthesis","volume":"177","author":"Alldred","year":"2009","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.nbd.2011.10.022","article-title":"Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction","volume":"45","author":"Alldred","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib3","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1523\/JNEUROSCI.3269-07.2007","article-title":"Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment","volume":"27","author":"Bell","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.59.2.198","article-title":"Natural history of mild cognitive impairment in older persons","volume":"59","author":"Bennett","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib5","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.neurobiolaging.2012.11.024","article-title":"Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease","volume":"34","author":"Berchtold","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jchemneu.2011.06.007","article-title":"Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease","volume":"42","author":"Blalock","year":"2011","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib7","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","article-title":"Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses","volume":"101","author":"Blalock","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib8","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/brain\/awq258","article-title":"Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease","volume":"133","author":"Bossers","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0197-4580(95)00035-D","article-title":"Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease","volume":"16","author":"Callahan","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/labinvest.3700005","article-title":"Amplification of RNA transcripts using terminal continuation","volume":"84","author":"Che","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jnr.10351","article-title":"Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling","volume":"70","author":"Colangelo","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JAD-2009-1196","article-title":"Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease","volume":"18","author":"Counts","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib14","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.64.12.1771","article-title":"Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease","volume":"64","author":"Counts","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000333122","article-title":"Hippocampal drebrin loss in mild cognitive impairment","volume":"10","author":"Counts","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00005072-200606000-00007","article-title":"Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment","volume":"65","author":"Counts","year":"2006","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib17","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1073\/pnas.1832384100","article-title":"Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity","volume":"100","author":"Deller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0079-6123(07)63040-4","article-title":"Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease","volume":"163","author":"deToledo-Morrell","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000256697.20968.d7","article-title":"Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease","volume":"68","author":"Devanand","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib20","doi-asserted-by":"crossref","first-page":"8310","DOI":"10.1523\/JNEUROSCI.21-21-08310.2001","article-title":"mRna expression analysis of tissue sections and single cells","volume":"21","author":"Eberwine","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/NEN.0b013e31818fc72f","article-title":"Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease","volume":"67","author":"Freeman","year":"2008","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymeth.2005.09.003","article-title":"RNA amplification strategies for small sample populations","volume":"37","author":"Ginsberg","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-59745-188-8_10","article-title":"Transcriptional profiling of small samples in the central nervous system","volume":"439","author":"Ginsberg","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2011.07.013","article-title":"Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease","volume":"45","author":"Ginsberg","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.biopsych.2010.05.030","article-title":"Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression","volume":"68","author":"Ginsberg","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410410211","article-title":"Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques","volume":"41","author":"Ginsberg","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A","article-title":"Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons","volume":"48","author":"Ginsberg","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0006-8993(91)90493-F","article-title":"Region-specific stability of dendritic extent in normal human aging and regression in Alzheimer's disease. I. CA1 of hippocampus","volume":"540","author":"Hanks","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.6474172","article-title":"Alzheimer's disease: cell-specific pathology isolates the hippocampal formation","volume":"225","author":"Hyman","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrn1685","article-title":"Integration of biochemical signalling in spines","volume":"6","author":"Kennedy","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1471-4159.2004.02888.x","article-title":"Synaptopodin, a molecule involved in the formation of the dendritic spine apparatus, is a dual actin\/alpha-actinin binding protein","volume":"92","author":"Kremerskothen","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib33","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1523\/JNEUROSCI.07-11-03474.1987","article-title":"Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats","volume":"7","author":"Lee","year":"1987","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neurobiolaging.2008.05.013","article-title":"Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology","volume":"31","author":"Liang","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/exnr.1999.7086","article-title":"Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment","volume":"158","author":"Mufson","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1023\/A:1020952704398","article-title":"Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease","volume":"27","author":"Mufson","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.neuro.26.041002.131445","article-title":"Cell biology of the presynaptic terminal","volume":"26","author":"Murthy","year":"2003","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib40","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","article-title":"Current concepts in mild cognitive impairment","volume":"58","author":"Petersen","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JAD-2005-7203","article-title":"Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction","volume":"7","author":"Reddy","year":"2005","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib42","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neuropharm.2013.10.018_bib43","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jnr.22227","volume":"88","author":"Sultana","year":"2010","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib45","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.ajpath.2011.07.044","article-title":"Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease","volume":"179","author":"Vana","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2013.10.018_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0197-4580(93)90113-P","article-title":"Regionally specific loss of neurons in the aging human hippocampus","volume":"14","author":"West","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2013.10.018_bib47","doi-asserted-by":"crossref","first-page":"e4936","DOI":"10.1371\/journal.pone.0004936","article-title":"Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease","volume":"4","author":"Williams","year":"2009","journal-title":"PLoS One"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813004942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813004942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T18:54:03Z","timestamp":1716058443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813004942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":47,"alternative-id":["S0028390813004942"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.018","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}